Rimegepant Sulfate

Brand name: Nurtec Odt

Rank #113 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$155.0M

Total Cost

Share:

106,692

Total Claims

$155.0M

Total Cost

3,508

Prescribers

$1,453

Cost per Claim

13,273

Beneficiaries

109,328

30-Day Fills

$44K

Avg Cost/Provider

30

Avg Claims/Provider

Share of Medicare Part D Spending

0.06%

of total Medicare Part D spending

$155.0M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $155.0M total

🔎 Data Overview

💰

At $1,453 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

👤

Average cost of $11,676 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Rimegepant Sulfate

#ProviderSpecialtyLocationClaimsCost
1Fernando Gonzales-PortilloInternal MedicineOrlando, FL755$1.3M
2Casilda BalmacedaNeurologyNew York, NY488$784K
3Robert PearlmanNeurologyBirmingham, AL374$544K
4Naga Lakshmana NidadavoluNeurologySaint Cloud, FL309$542K
5Igor CohenNeurologyAstoria, NY296$538K
6Marina NeystatNeurologyForest Hills, NY401$537K
7Maria DolgovinaNeurologyForest Hills, NY260$475K
8Michael AmoashiyNeurologyBrooklyn, NY251$453K
9Stephanie KhanNurse PractitionerForest Hills, NY215$442K
10Mimi SohnNeurologyCharleston, SC253$419K
11Farhad Kadkhodaei ElyaderaniNeurologyBronx, NY178$341K
12Ivan MikolaenkoCritical Care (Intensivists)Rockville Centre, NY197$337K
13Lance KimNeurologyOcala, FL234$328K
14Elizabeth McintyrePhysician AssistantVentura, CA193$327K
15Eugeniu MunteanNeurologyFargo, ND185$299K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
110Pantoprazole Sodium (Pantoprazole Sodium)$165.1M10,061,854
111Lenvatinib Mesylate (Lenvima)$164.6M7,004
112Treprostinil (Tyvaso Dpi)$158.9M6,704
113Rimegepant Sulfate (Nurtec Odt)$155.0M106,692
114Teriparatide (Forteo)$153.9M38,259
115Ixekizumab (Taltz Autoinjector)$149.8M19,972
116Sofosbuvir/Velpatasvir (Epclusa)$149.4M6,544

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology